4.6 Article

Prdx5 in the Regulation of Tuberous Sclerosis Complex Mutation-Induced Signaling Mechanisms

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Medicinal

Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness

Tania Gamberi et al.

Summary: Auranofin, an oral gold(I) compound originally developed for rheumatoid arthritis, is now being investigated for oncological applications with potential antineoplastic activity. Studies have shown that Auranofin can be used as a single drug or in combination with other molecules to enhance anticancer effects or overcome chemoresistance. In addition to inhibiting thioredoxin reductase, Auranofin has been found to affect other interesting targets and pathways in different cancer types.

MEDICINAL RESEARCH REVIEWS (2022)

Article Multidisciplinary Sciences

Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer

Qingyuan Huang et al.

Summary: Mutations in TSC1 and TSC2 may affect antitumor immune response in lung cancer. The study found that TSC1/TSC2 knockout promotes PD-L1 expression and increases sensitivity to immune checkpoint blockade treatment.

SCIENCE ADVANCES (2022)

Review Genetics & Heredity

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Cong Luo et al.

Summary: Tuberous sclerosis complex (TSC) is a genetic syndrome with diverse clinical features and organ dysfunction. The hyperactivation of the mTOR pathway is associated with most clinical manifestations in TSC. Although mTOR inhibitors show potential in TSC treatment, adverse events and poor response in some patients remain challenges. Thus, indicators are needed to predict the efficacy of mTOR inhibitors.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Oncology

Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma

Ruoyan Cao et al.

Summary: The peroxidase family of peroxiredoxins (PRDXs) plays a vital role in maintaining the intracellular balance of ROS in head and neck squamous cell carcinoma (HNSCC). The expression of PRDX1, PRDX4, and PRDX5 in HNSCC is increased, while the expression of PRDX2 is decreased. Higher expression of PRDX4/5/6 indicates poor prognosis, while lower expression of PRDX1/5 is associated with more immune cell infiltration, higher expression of immune-related molecules, and a likely response to anti-PD-1 treatment. Knockdown of PRDX5 inhibits HNSCC cell proliferation, invasion, and metastasis, and promotes apoptosis through its antioxidant property. This study highlights the potential role of PRDXs, particularly PRDX5, in HNSCC and suggests it as a potential therapeutic target.

FRONTIERS IN ONCOLOGY (2022)

Article Neurosciences

Ingenuity pathway analysis of α-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases

Sharad Kumar Suthar et al.

Summary: Despite the ambiguous understanding of the canonical signaling, interaction network molecules, biological functions, and role of alpha-synuclein, the use of artificial intelligence and Bioinformatics tools like ingenuity pathway analysis (IPA) have allowed us to analyze and predict the key pathways and interactions of alpha-synuclein. The study reveals neuroinflammation, Huntington's disease, and sirtuin signaling as the important pathways, and predicts Parkinson's disease as the key toxicity pathway of alpha-synuclein.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)

Review Cell Biology

Beyond controlling cell size: functional analyses of S6K in tumorigenesis

Xueji Wu et al.

Summary: S6K, as a substrate and major effector of mTORC1, not only controls cell size but also plays crucial roles in cell apoptosis, metabolism, and feedback regulation of upstream signals.

CELL DEATH & DISEASE (2022)

Article Medicine, Research & Experimental

ROS-mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC

Xiang Cao et al.

Summary: The study found PRDX5 to be highly expressed in non-small cell lung cancer tissues, and its demethylation status in the promoter region was related to the TNM stage. The binding of STAT3 to PRDX5 promoter region enhanced PRDX5 protein expression. PRDX5 promoted cell migration and invasion under oxidative stress conditions in NSCLC through activation of the Nrf2 signaling pathway.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma

Sinan Xiong et al.

Summary: In multiple myeloma, cells experience both endoplasmic reticulum stress and oxidative stress, leading to cell fate decision through common signaling pathways and inter-organelle communication, ultimately resulting in apoptosis. The mutual activation between endoplasmic reticulum stress and oxidative stress forms a self-perpetuating cycle, contributing to the understanding of MM pathogenesis and drug resistance. Research focusing on targeting redox signaling and endoplasmic reticulum stress responses is highlighted for future anti-myeloma therapy development.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Biochemistry & Molecular Biology

Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited

ElHusseiny M. M. Abdelwahab et al.

Summary: This study investigates the deregulation of cell death processes in TSC mutation, and identifies a potential treatment strategy involving the use of Proxison and rapamycin in combination to increase ROS production, modify miRNA expression pattern, and reduce cell viability.

APOPTOSIS (2021)

Review Medicine, Research & Experimental

PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review)

Daniela Miricescu et al.

Summary: Renal cell carcinoma (RCC) is the major type of renal malignancies, predominantly affecting males. The dysregulation of the PI3K/AKT/mTOR signaling pathway is frequently reported in RCC, associated with aggressive development and poor survival rate. mTOR inhibitors are currently used for RCC treatment to inhibit cell proliferation, growth, survival, and the cell cycle.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Review Medicine, General & Internal

Recent Updates on the Involvement of PI3K/AKT/mTOR Molecular Cascade in the Pathogenesis of Hyperproliferative Skin Disorders

Laura Mercurio et al.

Summary: PI3K represents a family of kinases that control multiple biological processes in mammalian cells and is associated with various skin pathologies. The dysregulation of PI3K/AKT/mTOR pathway contributes to uncontrolled cell proliferation and resistance to apoptosis in skin cancers, while also leading to enhanced proliferation, defective differentiation, and anti-apoptosis in psoriasis. The role of PI3K/AKT/mTOR in atopic dermatitis is less characterized, with recent evidence highlighting its function in epidermal barrier formation and stratification.

FRONTIERS IN MEDICINE (2021)

Article Oncology

Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations

Elhusseiny Mohamed Mahmoud Abdelwahab et al.

Summary: The study found that TSC mutation leads to dysregulation of vitamin A metabolic enzymes and downregulation of RARβ, while RA can restore RARβ levels and limit cell migration with minimal effect on proliferation. Combination of RA and rapamycin can normalize enzyme expression and activity, restore RARβ expression, and reduce cell proliferation and migration.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, Research & Experimental

Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors

Yiqun Xia et al.

Summary: The study identified a synergistic lethal interaction between mTOR and TrxR inhibitors, triggering oxidative stress and activating multiple signaling pathways to induce cancer cell death. The combination of Auranofin and Everolimus showed promising efficacy in suppressing tumor growth with minimal toxicity, suggesting a potential therapeutic strategy for cancer treatment.

THERANOSTICS (2021)

Review Neurosciences

Pediatric low-grade glioma in the era of molecular diagnostics

Scott Ryall et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

NRF2, a Transcription Factor for Stress Response and Beyond

Feng He et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Medicine, General & Internal

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence

Salihanur Darici et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Biochemistry & Molecular Biology

Which Antioxidant System Shapes Intracellular H2O2 Gradients?

Natalie M. Mishina et al.

ANTIOXIDANTS & REDOX SIGNALING (2019)

Review Biochemistry & Molecular Biology

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy

Tian Tian et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Cell Biology

mTOR Signalling in Head and Neck Cancer: Heads Up

Fiona H. Tan et al.

Article Biochemistry & Molecular Biology

Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug

Xiaonan Zhang et al.

BIOCHIMIE (2019)

Article Biotechnology & Applied Microbiology

Prognostic roles of mRNA expression o f peroxiredoxins in lung cancer

Liangyuan Chen et al.

ONCOTARGETS AND THERAPY (2018)

Review Oncology

The role of peroxiredoxins in cancer

Arianna Nicolussi et al.

MOLECULAR AND CLINICAL ONCOLOGY (2017)

Editorial Material Cell Biology

Genetics of renal cancer: focus on MTOR

Arindam P. Ghosh et al.

AGING-US (2016)

Review Biochemistry & Molecular Biology

Endoplasmic Reticulum Stress and Associated ROS

Hafiz Maher Ali Zeeshan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Editorial Material Cell Biology

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy

Alexandr V. Bazhin et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Multidisciplinary Sciences

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer

Yujun Hao et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide

Venkat R. Pannala et al.

FREE RADICAL BIOLOGY AND MEDICINE (2015)

Article Pharmacology & Pharmacy

Auranofin: Repurposing an Old Drug for a Golden New Age

Christine Roder et al.

DRUGS IN R&D (2015)

Article Oncology

Tissue thioredoxin reductase-1 expression in astrocytomas of different grades

Hasan Esen et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

Review Biochemistry & Molecular Biology

Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease

Stewart Siyan Cao et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Review Pharmacology & Pharmacy

Targeting antioxidants for cancer therapy

Andrea Glasauer et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Article Microbiology

A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia

Noa Tejman-Yarden et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Biochemistry & Molecular Biology

Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death

Stephanie De Simoni et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Review Biotechnology & Applied Microbiology

Modulation of oxidative stress as an anticancer strategy

Chiara Gorrini et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Biochemistry & Molecular Biology

mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway

H. Kato et al.

CELL DEATH AND DIFFERENTIATION (2012)

Review Cell Biology

AMPK: a nutrient and energy sensor that maintains energy homeostasis

D. Grahame Hardie et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Review Biochemistry & Molecular Biology

Peroxiredoxin 5: Structure, Mechanism, and Function of the Mammalian Atypical 2-Cys Peroxiredoxin

Bernard Knoops et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Article Oncology

mTOR Inhibitors in Advanced Renal Cell Carcinoma

Martin H. Voss et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)

Article Biochemistry & Molecular Biology

Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1

Katrin Duevel et al.

MOLECULAR CELL (2010)

Article Medicine, Research & Experimental

mTOR Signaling in Lymphangioleiomyomatosis

Arnold S. Kristof

LYMPHATIC RESEARCH AND BIOLOGY (2010)

Review Cell Biology

The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein

Zhaohui Feng et al.

TRENDS IN CELL BIOLOGY (2010)

Review Biochemistry & Molecular Biology

Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects

Erika Fernandez-Vizarra et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)

Review Pathology

Endoplasmic reticulum stress in disease pathogenesis

Jonathan H. Lin et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)

Article Multidisciplinary Sciences

A chemical method for fast and sensitive detection of DNA synthesis in vivo

Adrian Salic et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Oncology

Rapamycin: An anti-cancer immunosuppressant?

BK Law

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)

Article Endocrinology & Metabolism

Peroxiredoxin 5 expression in the human thyroid gland

AC Gérard et al.

THYROID (2005)

Article Biochemistry & Molecular Biology

Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate

MS Seo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)